P21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal

EMBO Reports

Volumn 2, Issue 1, 2001, Pages 27-34

  Zezula, Jürgen ^a   Casaccia Bonnefil, Patrizia ^b,c   Ezhevsky, Sergei A ^d   Osterhout, Donna J ^b   Levine, Joel M ^e   Dowdy, Steve F ^d   Chao, Moses V ^b   Koff, Andrew ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN P16; PROTEIN P21; PROTEIN P27; ROSCOVITINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ANTIMETABOLITE; BROXURIDINE; CDKN1A PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; ENZYME INHIBITOR; FLAVONOID; MAP2K1 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN P16INK4A; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL TYPE; CEREBELLUM; CONTROLLED STUDY; IN VIVO STUDY; LIFE; MITOSIS INHIBITION; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSDUCTION; GENOTYPE; IMMUNOHISTOCHEMISTRY; KINETICS; METABOLISM; NEWBORN; PHYSIOLOGY; TIME;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; ANTIMETABOLITES; BRAIN; BROMODEOXYURIDINE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; ENZYME INHIBITORS; FLAVONOIDS; GENOTYPE; IMMUNOHISTOCHEMISTRY; KINETICS; MAP KINASE KINASE 1; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OLIGODENDROGLIA; PROTEIN-SERINE-THREONINE KINASES; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0034745384     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1093/embo-reports/kve008     Document Type: Article

References (44)

1. Radiation-induced cell cycle arrest compromised by p21 deficiency
2. Kip1
3. Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation
4. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
5. Kip1
6. WAF1/CIP1/SDI1
7. Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
8. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein
9. Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment
10. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb
11. Oligodendrocyte precursor cells count time but not cell divisions before differentiation
12. 1 cell cycle arrest in oligodendrocyte progenitors
13. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro
14. 1/S cell-cycle control contributing to carcinogenesis
15. Cip1
16. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
17. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
18. The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker
19. Plasticity of developing cerebellar cells in vitro studied with antibodies against the NG2 antigen
20. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
21. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
22. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5
23. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression
24. Principles of CDK regulation
25. The dynamics of cyclin dependent kinase structure
26. Kip1 induces cell migration
27. p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina
28. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator
29. The oligodendrocyte and its many cellular processes
30. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo
31. Evolving ideas about cyclins
32. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics
33. In vivo protein transduction: Delivery of a biologically active protein into the mouse
34. Protein transduction, unrestricted delivery into all cells?
35. 1 cyclins and cell cycle progression
36. 1 cyclin-dependent kinases
37. 1-phase progression
38. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
39. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
40. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation
41. Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes
42. Differentiation of a bipotential glial progenitor cell in a single cell microculture
43. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
44. 1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF